Article Information
History
- September 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- J Gonzalo Acevedo-Rodriguez, MD1,*,
- Carlos Zamudio, MD1,
- Noah Kojima, MD2,
- Fiorella Krapp, MD, MSc1,
- Pablo Tsukayama, PhD, MSc1,
- C Stefany Neciosup-Vera, MSc3 and
- Eduardo Gotuzzo, MD, FACP, FIDSA1
- 1Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú
- 2Centers for Disease Control and Prevention, Atlanta, Georgia, U.S.A
- 3Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Perú
- ↵*Corresponding Author Contact Information:
J Gonzalo Acevedo-Rodriguez, MD. Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, San Martin de Porres, 15102, Lima-Peru (juan.acevedo{at}upch.pe).
Posted September 08, 2023.
Interim influenza vaccine effectiveness estimates during the 2023 Southern Hemisphere season
